$30.30
+
$0.39 (1.30%)
End-of-day quote: 07/30/2021
NasdaqCM:ARPO
Aerpio Pharmaceuticals Annual Report
| Year | Year | 2021 | ||
|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | |
| GM % | Gross Margin % |
|
0.00% | |
| OM | Operating Margin |
|
0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $0.00 |
| Div. | Dividends |
|
$0.00 | |
| PR % | Payout Ratio % |
|
0 | |
| Sha. | Shares |
|
47.31m | |
| OCF | Operating Cash Flow |
|
$0.00M | |
| FCF | Free Cash Flow |
|
$0.00M | |
| FCFS | Free Cash Flow Per Share |
|
$0.00 |
